Search

everythinglearnresearchcommunity

for

Search:↓

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

Most patients with alopecia areata in Syria are young adult males, often with patchy scalp hair loss.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Tofacitinib is effective and safe for treating severe alopecia areata.

Plica neuropathica can occur with diffuse alopecia and should be considered in diagnosis.

Alopecia areata in children shows varied symptoms and may involve nails, needing further evaluation for other health issues.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.